Mergers & Acquisitions ·
On July 27, 2026, Avanos Medical, Inc. completed its merger with a subsidiary of American Industrial Partners (AIP)…
AVNSAvanos Medical, Inc.
On July 27, 2026, Avanos Medical, Inc. completed its merger with a subsidiary of American Industrial Partners (AIP), resulting in the company becoming a wholly-owned private subsidiary. Public shareholders received $25.00 per share in cash, representing an aggregate transaction value of approximately $1.2 billion to $1.272 billion. Concurrently, Avanos entered into a new credit agreement providing $675 million in initial term loans, $100 million in delayed draw commitments, and a $100 million revolving facility, while repaying all prior debt. Trading of Avnos common stock was suspended on the NYSE, and the company intends to deregister its securities with the SEC. The existing board resigned and was replaced by appointees from AIP, including David C. Pacitti as CEO. Avanos Medical operates in the medical technology industry, developing and manufacturing medical device solutions for patient nutrition and pain management.